SAGENT Pharmaceuticals is an innovative company based upon a unique business model that allows us to be more responsive than many of the non-branded injectables companies with which you may now be working.
Trust SAGENT for what you need
• A focus on enhanced, ready-to-use products that help increase efficiency, safety and ease of use
• Labels designed with safety and the reduction of medication errors in mind
• Traditionally difficult-to-manufacture injectables
• Products that other firms are unwilling to commercialize, such as
— niche products
— discontinued products
— small volume products
• Injectables that will cover a wide array of therapeutic classes
• Injectables that meet stringent FDA requirements and that are latex-free and bar-coded
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 11/01/07 | Series A | 58M | Vivo Ventures | Unknown |
People
Jeffrey Yordon (CEO)
Ronald Pauli (CFO)
View more details about the people at Sagent Pharmaceuticals